These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2829665)

  • 1. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.
    Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE
    Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.
    McGregor S; Easterday BC; Kaplan AS; Ben-Porat T
    Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
    Kit S; Kit M; Pirtle EC
    Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity.
    Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J
    Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
    Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic engineering of the pseudorabies virus genome to construct live vaccines.
    Post LE; Thomsen DR; Petrovskis EA; Meyer AL; Berlinski PJ; Wardley RC
    J Reprod Fertil Suppl; 1990; 41():97-104. PubMed ID: 2170641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
    van Oirschot JT; Daus F; Kimman TG; van Zaane D
    Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of mice and swine with a pseudorabies virus mutant lacking thymidine kinase activity.
    McFarland MD; Hill HT
    Can J Vet Res; 1987 Jul; 51(3):340-4. PubMed ID: 2820561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
    Arellano PE; Morrison RB; Molitor TW; Thawley DG
    J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine.
    Vandeputte J; Chappuis G; Fargeaud D; Précausta P; Guillemin F; Brun A; Desmettre P; Stellmann C
    Am J Vet Res; 1990 Jul; 51(7):1100-6. PubMed ID: 2167620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs.
    McCaw MB; Xu J
    Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
    Cook DR; Hill HT; Kinker DR
    Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence and pathogenesis of non-virulent and virulent strains of pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus.
    Mulder WA; Priem J; Glazenburg KL; Wagenaar F; Gruys E; Gielkens AL; Pol JM; Kimman TG
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():117-24. PubMed ID: 8113720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.